Novo Nordisk Aktie
79,43
EUR
-20,12
EUR
-20,21
%
79,79
EUR
-19,51
EUR
-19,65
%
Novo Nordisk Aktie Analyse
31.03.20 | Novo Nordisk Neutral | Oddo BHF | |
24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.03.20 | Novo Nordisk buy | UBS AG | |
18.03.20 | Novo Nordisk Outperform | Bernstein Research | |
17.03.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.03.20 | Novo Nordisk overweight | Barclays Capital | |
02.03.20 | Novo Nordisk overweight | Barclays Capital | |
Werbung
|
|||
25.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.02.20 | Novo Nordisk Hold | Deutsche Bank AG | |
06.02.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.02.20 | Novo Nordisk Neutral | UBS AG | |
06.02.20 | Novo Nordisk overweight | Barclays Capital | |
06.02.20 | Novo Nordisk Outperform | Bernstein Research | |
06.02.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.02.20 | Novo Nordisk overweight | Barclays Capital | |
05.02.20 | Novo Nordisk Outperform | Bernstein Research | |
05.02.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
05.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
31.01.20 | Novo Nordisk overweight | Barclays Capital | |
29.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
27.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.01.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
20.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.01.20 | Novo Nordisk overweight | Barclays Capital | |
17.01.20 | Novo Nordisk Neutral | UBS AG | |
17.01.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.01.20 | Novo Nordisk overweight | Barclays Capital | |
16.01.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.01.20 | Novo Nordisk neutral | Morgan Stanley | |
06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.01.20 | Novo Nordisk kaufen | Bernstein Research | |
17.12.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
12.12.19 | Novo Nordisk Hold | Deutsche Bank AG | |
06.12.19 | Novo Nordisk Neutral | UBS AG | |
27.11.19 | Novo Nordisk Reduce | HSBC | |
21.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
21.11.19 | Novo Nordisk Neutral | UBS AG | |
21.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
18.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.11.19 | Novo Nordisk Neutral | UBS AG | |
18.11.19 | Novo Nordisk overweight | Barclays Capital | |
11.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
06.11.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
04.11.19 | Novo Nordisk Outperform | Credit Suisse Group | |
04.11.19 | Novo Nordisk Equal weight | Barclays Capital | |
04.11.19 | Novo Nordisk Hold | Deutsche Bank AG | |
04.11.19 | Novo Nordisk Outperform | Bernstein Research |